Less Ads, More Data, More Tools Register for FREE

Pin to quick picksWh Smith Regulatory News (SMWH)

Share Price Information for Wh Smith (SMWH)

Share Price is delayed by 15 minutes
Get Live Data
506.00    -2.00 (-0.39%)
Bid:
503.50
Ask:
505.00
Spread: 1.50 (0.298%)
Market Cap: £630.96m
SMWH Live PriceLast checked at - London Stock Exchange

Intraday Wh Smith Share Chart

Trading Statement

12 Mar 2020 07:00

RNS Number : 8459F
WH Smith PLC
12 March 2020
 

 

 

12 March 2020

 

WH SMITH PLC

 

 

First Half Trading and Covid-19 Update

 

 

In light of current equity market conditions and the rapidly changing developments regarding Covid-19, the WH Smith Group provides the following update.

 

First Half Trading Update:

 

For the first half of the year to 29 February 2020, Group total revenue was up 7% with like-for-like (LFL) revenue down 1%. Total revenue in Travel was up 19% with LFL revenue up 2%. In High Street, total revenue was down 5% with LFL revenue down 4%. As a result, the Group is confident that underlying profit before tax for the first half, which will be reported on 22 April 2020, will be in line with market expectations.

 

Covid-19 Update:

 

WH Smith's key priority is the health and safety of its employees, customers and business partners.

 

The Group has been monitoring the financial impact of Covid-19 since the outbreak began across both its Travel and High Street businesses. In Asia Pacific, which accounts for approximately 5% of Travel's revenue, we have seen a significant impact on the business since February. In addition, over the last two weeks, the Group has started to see a material reduction in passenger numbers at airports outside of Asia Pacific in the UK (approximately 60% of Travel's revenue), the US (approximately 25% of Travel's revenue) and in Europe.

 

The Group is managing the business to protect profitability and is taking all necessary action to reduce costs. Based on current trading and modelling, the Group believes that the effects of Covid-19 will result in a reduction in our expectations for revenue and profit across the Travel business for the second half. Today, the Company is therefore providing guidance on the impact on full year results of Covid-19 based on an assumption of a challenging third quarter and a modest normalisation in the fourth quarter. For UK Travel, we expect revenue for the six months to be down approximately 15% on expectations which includes airports, our most affected channel, down 35% in March and April. On the same basis, including significant reductions in March and April, second half revenue in the US is expected to be approximately 20% lower than our expectations. The rest of our International business is also expected to be approximately 20% lower.

 

Clearly, the position is evolving fast and the Group will provide a further update at its Interim results on 22 April 2020.

 

While the Group is currently not seeing a significant impact on its High Street business, it recognises that Covid-19 could result in reduced high street footfall.

 

As a result, the Group currently estimates an adverse impact in the financial year ending 31 August 2020 of between £100m and £130m on the Group's revenue and between £30m and £40m on underlying Group profit before tax.

 

WH Smith is a resilient business with a strong balance sheet, substantial cash liquidity and strong cashflow. The Group has a strong management team in place and has consistently demonstrated that it can adapt and respond quickly to changing market conditions.

 

Over the longer term, the Board remains confident in the strategy and believes the Group is well positioned to benefit from the normalisation and growth of the global travel market.

 

 

Enquiries:

 

WH Smith PLC

Nicola Hillman Media Relations 01793 56 3354

Mark Boyle Investor Relations 020 3981 1285

 

Brunswick

Fiona Micallef-Eynaud / Camille Ng 020 7404 5959

  Advance Notice of Interim Results

WH Smith PLC will announce its Interim Results 2020 on Wednesday 22 April 2020.

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
TSTEAEDFFEEEEAA
Date   Source Headline
4th Jun 20269:23 amRNSHolding(s) in Company
29th May 202611:00 amRNSTotal Voting Rights
20th May 20265:12 pmRNSDirector/PDMR Shareholding
30th Apr 202611:08 amRNSTotal Voting Rights
29th Apr 202610:25 amRNSHolding(s) in Company
29th Apr 202610:19 amRNSHolding(s) in Company
27th Apr 20263:57 pmRNSDirector/PDMR Shareholding
23rd Apr 20267:01 amRNSBoard changes
23rd Apr 20267:00 amRNSInterim Results Announcement
17th Apr 202611:06 amRNSHolding(s) in Company
16th Apr 202612:51 pmRNSHolding(s) in Company
16th Apr 20267:16 amRNSHolding(s) in Company
14th Apr 20266:03 pmRNSHolding(s) in Company
9th Apr 202610:11 amRNSHolding(s) in Company
7th Apr 20267:00 amRNSDirectorate change
31st Mar 202612:50 pmRNSTotal Voting Rights
23rd Mar 20269:21 amRNSHolding(s) in Company
9th Mar 20269:59 amRNSHolding(s) in Company
5th Mar 20267:00 amRNSTrading update
27th Feb 202611:00 amRNSTotal Voting Rights
25th Feb 202610:32 amRNSBlock Listing Six Monthly Return
12th Feb 20269:17 amRNSNotice of GM
3rd Feb 20269:56 amRNSResult of AGM
30th Jan 202611:00 amRNSTotal Voting Rights
29th Jan 20264:41 pmRNSDirector/PDMR Shareholding
22nd Jan 202611:35 amRNSHolding(s) in Company
19th Jan 202611:58 amRNSHolding(s) in Company
19th Jan 20269:57 amRNSHolding(s) in Company
19th Jan 20269:53 amRNSHolding(s) in Company
19th Jan 20267:00 amRNSAppointment of Executive Chairman
9th Jan 202610:27 amRNSDirector Declaration
8th Jan 20264:36 pmRNSDirector/PDMR Shareholding
31st Dec 202511:00 amRNSTotal Voting Rights
31st Dec 202511:00 amRNSTotal Voting Rights
24th Dec 20251:29 pmRNSDirector/PDMR Shareholding
24th Dec 20251:29 pmRNSDirector/PDMR Shareholding
24th Dec 20251:24 pmRNSDirector/PDMR Shareholding
24th Dec 20251:24 pmRNSDirector/PDMR Shareholding
24th Dec 20251:22 pmRNSAnnual Financial Report
24th Dec 20251:22 pmRNSAnnual Financial Report
24th Dec 20251:16 pmRNSDirector/PDMR Shareholding
24th Dec 20251:16 pmRNSDirector/PDMR Shareholding
23rd Dec 202512:05 pmRNSHolding(s) in Company
23rd Dec 202512:05 pmRNSHolding(s) in Company
19th Dec 20259:14 amRNSDirectorate change
19th Dec 20259:14 amRNSDirectorate change
19th Dec 20257:00 amRNSPreliminary Results Announcement
19th Dec 20257:00 amRNSPreliminary Results Announcement
12th Dec 20257:00 amRNSRevised date of Preliminary Results publication
28th Nov 202510:11 amRNSTotal Voting Rights

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.